This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Sanofi. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 94 
1 out of 1,549 
Years Active: 2019
Title: Innovations by Jean-Marie Chambard: Pioneering Research in Nematode Acetylcholine Receptors
Introduction
Jean-Marie Chambard, an accomplished inventor based in Yerres, France, has made significant contributions to the field of biotechnology. With a focus on understanding and enhancing mammalian cell lines for practical applications, Chambard's innovations have the potential to impact health sciences greatly.
Latest Patents
Chambard holds a notable patent titled "Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays." This patent discloses mammalian cell lines that stably express functional nematode acetylcholine receptor subunits. The expression of functional ion channels has been achieved through the stable co-expression of the chaperone protein RIC3. These advanced cell lines are instrumental in high-throughput screening (HTS) assays, facilitating the identification of new candidate parasiticidal, including nematocidal, active ingredients.
Career Highlights
Throughout his career, Jean-Marie Chambard has worked with reputable organizations. Notably, he served at Boehringer Ingelheim Animal Health, Inc. and Sanofi, where he contributed to various innovative projects. His expertise in biochemistry and pharmacology has propelled his career, making him a recognized figure in his field.
Collaborations
Chambard has collaborated with several talented individuals, including his coworkers Lance Hammerland and Brenda Bondesen. These partnerships underscore the importance of teamwork in driving scientific discoveries and advancing technology within the pharmaceutical and biotechnology sectors.
Conclusion
In summary, Jean-Marie Chambard has established himself as a pioneer in the development of mammalian cell lines for high-throughput screening of potential therapeutics. His innovative patent showcases the importance of collaborative efforts and technical expertise in addressing challenges in parasitic disease management. As the research continues to evolve, Chambard's contributions will undoubtedly play a vital role in the future of biotechnology and pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile